Regions Financial Corp Johnson & Johnson Transaction History

Regions Financial Corp

$13.1 Billion
Q2 2024

A detailed history of Regions Financial Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Regions Financial Corp holds 643,380 shares of JNJ stock, worth $100 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

643,380

Previous 654,579 1.71%

Holding current value

$100 Million

Previous $104 Million 9.19%

% of portfolio

0.72%

Previous 0.79%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$144.38 - $157.78 $1.62 Million - $1.77 Million	-11,199 Reduced 1.71%	643,380 $94 Million
Q1 2024 Apr 23, 2024	SELL	$155.22 - $162.74 $1.99 Million - $2.08 Million	-12,793 Reduced 1.92%	654,579 $104 Million
Q4 2023 Feb 06, 2024	SELL	$145.6 - $158.88 $2.77 Million - $3.02 Million	-19,039 Reduced 2.77%	667,372 $105 Million
Q3 2023 Nov 01, 2023	SELL	$155.75 - $174.48 $916,121 - $1.03 Million	-5,882 Reduced 0.85%	686,411 $107 Million
Q2 2023 Aug 09, 2023	SELL	$154.35 - $166.11 $6.19 Million - $6.66 Million	-40,078 Reduced 5.47%	692,293 $115 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $434,570 - $518,608	-2,877 Reduced 0.39%	732,371 $114 Million
Q4 2022 Feb 03, 2023	SELL	$160.2 - $179.79 $130,242 - $146,169	-813 Reduced 0.11%	735,248 $130 Million
Q3 2022 Nov 03, 2022	SELL	$161.33 - $179.52 $1.14 Million - $1.27 Million	-7,047 Reduced 0.95%	736,061 $120 Million
Q2 2022 Jul 25, 2022	SELL	$168.19 - $186.01 $5.01 Million - $5.54 Million	-29,806 Reduced 3.86%	743,108 $132 Million
Q1 2022 Apr 25, 2022	BUY	$158.14 - $179.59 $11.3 Million - $12.9 Million	71,730 Added 10.23%	772,914 $137 Million
Q4 2021 Jan 31, 2022	SELL	$155.93 - $173.01 $1.4 Million - $1.55 Million	-8,948 Reduced 1.26%	701,184 $120 Million
Q3 2021 Nov 04, 2021	SELL	$161.5 - $179.47 $2.38 Million - $2.65 Million	-14,753 Reduced 2.04%	710,132 $115 Million
Q2 2021 Jul 27, 2021	SELL	$159.48 - $171.07 $1.39 Million - $1.49 Million	-8,735 Reduced 1.19%	724,885 $119 Million
Q1 2021 Jun 02, 2021	SELL	$153.07 - $170.48 $645,036 - $718,402	-4,214 Reduced 0.57%	733,620 $121 Million
Q4 2020 Feb 05, 2021	BUY	$137.11 - $157.38 $630,843 - $724,105	4,601 Added 0.63%	737,834 $116 Million
Q3 2020 Oct 15, 2020	SELL	$140.38 - $153.83 $477,151 - $522,868	-3,399 Reduced 0.46%	733,233 $109 Million
Q2 2020 Jul 27, 2020	BUY	$128.81 - $155.51 $10.6 Million - $12.8 Million	82,139 Added 12.55%	736,632 $104 Million
Q1 2020 Apr 29, 2020	BUY	$111.14 - $153.99 $26.4 Million - $36.6 Million	237,506 Added 56.96%	654,493 $85.8 Million
Q4 2019 Feb 03, 2020	SELL	$127.5 - $146.44 $2.32 Million - $2.66 Million	-18,192 Reduced 4.18%	416,987 $60.8 Million
Q3 2019 Oct 24, 2019	SELL	$126.95 - $142.14 $2.15 Million - $2.41 Million	-16,973 Reduced 3.75%	435,179 $56.3 Million
Q2 2019 Jul 19, 2019	SELL	$131.15 - $144.24 $2.12 Million - $2.33 Million	-16,183 Reduced 3.46%	452,152 $63 Million
Q1 2019 Apr 19, 2019	SELL	$125.72 - $139.79 $1.21 Million - $1.35 Million	-9,663 Reduced 2.02%	468,335 $65.5 Million
Q4 2018 Jan 28, 2019	SELL	$122.84 - $147.84 $270,493 - $325,543	-2,202 Reduced 0.46%	477,998 $61.7 Million
Q3 2018 Oct 22, 2018	SELL	$121.58 - $142.88 $836,105 - $982,585	-6,877 Reduced 1.41%	480,200 $66.4 Million
Q2 2018 Jul 26, 2018	SELL	$119.4 - $131.76 $3.43 Million - $3.78 Million	-28,725 Reduced 5.57%	487,077 $59.1 Million
Q1 2018 Apr 18, 2018	SELL	$125.1 - $148.14 $4.64 Million - $5.49 Million	-37,053 Reduced 6.7%	515,802 $66.1 Million
Q4 2017 Jan 18, 2018	SELL	$131.22 - $143.62 $2.58 Million - $2.82 Million	-19,650 Reduced 3.43%	552,855 $77.2 Million
Q3 2017 Oct 23, 2017	BUY	$129.47 - $135.38 $74.1 Million - $77.5 Million	572,505	572,505 $74.4 Million

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Account

Regions Financial Corp Johnson & Johnson Transaction History